MATWIN ANNUAL REPORT 2019 stephanie.dhont2020-05-06T09:56:59+02:00 Partagez cette histoire, choisissez votre plate-forme ! FacebookTwitterRedditLinkedInTumblrPinterest Related Posts BIPER THERAPEUTICS RAISES €1.25 MILLION BIPER THERAPEUTICS RAISES €1.25 MILLION Partnership MATWIN and European Health Investor Network Partnership MATWIN and European Health Investor Network Genoscience Pharma receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma Genoscience Pharma receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma First US leukemia patient dosed with investigational SMART101 cell therapy First US leukemia patient dosed with investigational SMART101 cell therapy Brenus Pharma and InSphero receive €1.5 million in grants for the collaborative project “STC-1010” Brenus Pharma and InSphero receive €1.5 million in grants for the collaborative project “STC-1010”
